Literature DB >> 25107563

Blocking innate immunity to slow the progression of chronic kidney disease.

Christoph Schmaderer1, Uwe Heemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25107563     DOI： 10.1007/s00210-014-1031-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  16 in total

1.  Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

Authors:  Dick de Zeeuw; Tadao Akizawa; Paul Audhya; George L Bakris; Melanie Chin; Heidi Christ-Schmidt; Angie Goldsberry; Mark Houser; Melissa Krauth; Hiddo J Lambers Heerspink; John J McMurray; Colin J Meyer; Hans-Henrik Parving; Giuseppe Remuzzi; Robert D Toto; Nosratola D Vaziri; Christoph Wanner; Janet Wittes; Danielle Wrolstad; Glenn M Chertow
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

2.  Protective effects of Toll-like receptor 4 inhibitor eritoran on renal ischemia-reperfusion injury.

Authors:  M Liu; M Gu; D Xu; Q Lv; W Zhang; Y Wu
Journal:  Transplant Proc       Date:  2010-06       Impact factor: 1.066

Review 3.  Sequential RAAS blockade: is it worth the risk?

Authors:  Frederik Persson; Peter Rossing
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

4.  Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.

Authors:  A Szabo; J Lutz; K Schleimer; B Antus; P Hamar; T Philipp; U Heemann
Journal:  Kidney Int       Date:  2000-03       Impact factor: 10.612

5.  Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.

Authors:  Marcia Venegas-Pont; Michaele B Manigrasso; Samira C Grifoni; Babbette B LaMarca; Christine Maric; Lorraine C Racusen; Porter H Glover; Allison V Jones; Heather A Drummond; Michael J Ryan
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

6.  Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury.

Authors:  Krisztina Rusai; Daniel Sollinger; Marcus Baumann; Bettina Wagner; Matthias Strobl; Christoph Schmaderer; Marcel Roos; Carsten Kirschning; Uwe Heemann; Jens Lutz
Journal:  Pediatr Nephrol       Date:  2010-02-04       Impact factor: 3.714

7.  Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats.

Authors:  Mitsuhiro Kondo; Atsuo Tahara; Kazumi Hayashi; Masaki Abe; Hiroshi Inami; Takeshi Ishikawa; Hiroyuki Ito; Yuichi Tomura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-23       Impact factor: 3.000

8.  Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury.

Authors:  Krisztina Rusai; Hai Huang; Nora Sayed; Matthias Strobl; Marcel Roos; Christoph Schmaderer; Uwe Heemann; Jens Lutz
Journal:  Transpl Int       Date:  2008-03-18       Impact factor: 3.782

9.  Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.

Authors:  Steven M Opal; Pierre-Francois Laterre; Bruno Francois; Steven P LaRosa; Derek C Angus; Jean-Paul Mira; Xavier Wittebole; Thierry Dugernier; Dominique Perrotin; Mark Tidswell; Luis Jauregui; Kenneth Krell; Jan Pachl; Takeshi Takahashi; Claus Peckelsen; Edward Cordasco; Chia-Sheng Chang; Sandra Oeyen; Naoki Aikawa; Tatsuya Maruyama; Roland Schein; Andre C Kalil; Marc Van Nuffelen; Melvyn Lynn; Daniel P Rossignol; Jogadish Gogate; Mary B Roberts; Janice L Wheeler; Jean-Louis Vincent
Journal:  JAMA       Date:  2013-03-20       Impact factor: 56.272

10.  Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.

Authors:  Shijun Wang; Christoph Schmaderer; Eva Kiss; Claudia Schmidt; Mahnaz Bonrouhi; Stefan Porubsky; Norbert Gretz; Liliana Schaefer; Carsten J Kirschning; Zoran V Popovic; Hermann-Josef Gröne
Journal:  Dis Model Mech       Date:  2009-12-28       Impact factor: 5.758
View more
  2 in total

Review 1.  Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.

Authors:  Maurizio Salvadori; Giuseppina Rosso; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2015-06-24

2.  Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Authors:  Marta Martin-Lorenzo; Laura Gonzalez-Calero; Paula J Martinez; Montserrat Baldan-Martin; Juan Antonio Lopez; Gema Ruiz-Hurtado; Fernando de la Cuesta; Julián Segura; Jesús Vazquez; Fernando Vivanco; Maria G Barderas; Luis M Ruilope; Gloria Alvarez-Llamas
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.